General Information of Drug (ID: DMDMXKQ)

Drug Name
GSK1292263 Drug Info
Cross-matching ID
PubChem CID
24996872
ChEBI ID
CHEMBL3187503
CAS Number
CAS 1032823-75-8
TTD Drug ID
D0S4II

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
TNF signaling pathway 2.17 0.00e+0 103/112 (91.96%) CXCL2;CXCL3;CXCL1;...
Amoebiasis 2.13 0.00e+0 99/102 (97.06%) CXCL2;CXCL8;CXCL3;...
IL-17 signaling pathway 2.09 0.00e+0 84/94 (89.36%) CXCL2;CXCL8;CXCL3;...
Rheumatoid arthritis 2.08 0.00e+0 78/93 (83.87%) CXCL2;CXCL8;CXCL3;...
Tryptophan metabolism 1.87 9.14e-3 35/42 (83.33%) DLD;KYNU;ALDH3A2;...
Legionellosis 1.87 7.61e-3 51/57 (89.47%) CXCL2;CXCL8;CXCL3;...
Focal adhesion 1.86 6.53e-3 180/201 (89.55%) SPP1;SRC;VEGFA;...
Asthma 1.81 2.43e-2 25/31 (80.65%) FCER1A;PRG2;HLA-DPA1;...
Viral protein interaction with cytokine and cytokine re... 1.80 2.41e-2 84/100 (84%) CXCL2;CXCL8;CXCL3;...
Lysine degradation 1.79 2.97e-2 51/63 (80.95%) PLOD2;DLD;ALDH3A2;...
Epithelial cell signaling in Helicobacter pylori infect... 1.77 3.11e-2 62/70 (88.57%) CXCL2;CXCL8;CXCL3;...
Glycolysis / Gluconeogenesis 1.74 4.28e-2 56/67 (83.58%) PGAM1;DLD;ENO2;...
AGE-RAGE signaling pathway in diabetic complications 1.74 4.22e-2 97/100 (97%) CXCL8;IL6;VEGFA;...
Huntington disease -1.70 4.46e-2 233/306 (76.14%) DNALI1;DCTN5;POLR2L;...
Bile secretion -1.71 4.48e-2 68/90 (75.56%) ATP1A1;SLC5A1;ADCY9;...
Steroid hormone biosynthesis -1.73 4.23e-2 43/61 (70.49%) CYP2E1;HSD11B1;HSD17B7;...
Complement and coagulation cascades -1.73 4.65e-2 76/85 (89.41%) SERPINA1;F13B;SERPINF2;...
Linoleic acid metabolism -1.80 3.02e-2 21/29 (72.41%) PLA2G2A;CYP2C8;PLA2G4C;...
Parkinson disease -1.88 4.23e-3 176/249 (70.68%) COX4I1;PSMC3;GPR37;...
Metabolism of xenobiotics by cytochrome P450 -1.92 0.00e+0 49/77 (63.64%) EPHX1;CYP2E1;HSD11B1;...
Retinol metabolism -1.93 0.00e+0 41/68 (60.29%) CYP3A5;UGT2B4;ALDH1A1;...
Oxidative phosphorylation -1.93 0.00e+0 93/133 (69.92%) COX6C;COX6B1;NDUFA5;...
Proteasome -2.12 0.00e+0 44/46 (95.65%) PSMD2;PSME4;PSME2;...
Mineral absorption -2.19 0.00e+0 48/60 (80%) ATP2B1;ATP2B2;ATOX1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.04uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.04uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.04uM - 10uM 24H